Advertisement: Mogrify
Advertisement: Cambridge Network
ARM Innovation Hub
RealVNC mid-banner general
Advertisement: EBCam mid banner
Advertisement: Simpsons Creative
Advertisement EY mid banner
RealVNC mid banner careers
Advertisement: China mid banner
Barr Ellison Solicitors – commercial property
Advertisement: RSM
Mid banner advertisement: BDO
16 August, 2006 - 11:45 By Staff Reporter

GeneMedix in arrangement with major company over restructuring plan

Newmarket biopharma, GeneMedix, has entered into a temporary exclusive arrangement with a “major company” in relation to the proposed restructuring of the firm.Newmarket biopharma, GeneMedix, has entered into a temporary exclusive arrangement with a “major company” in relation to the proposed restructuring of the firm.

In connection with the exclusivity arrangement, a bridging loan will be paid in instalments to GeneMedix, the first part of which has already been received.

The company has also received a second interim payment out of the total £1.6m it expects to receive from the sale of its Chinese facility, which it expects to complete over the coming months once approvals from the Chinese authorities have finally been obtained.

Add new comment

Newsletter Subscription

Stay informed of the latest news and features